Literature DB >> 32156115

Substrate Specificity of OXA-48 after β5-β6 Loop Replacement.

Laura Dabos1,2, Agustin Zavala3, Rémy A Bonnin1,2,4, Oliver Beckstein5, Pascal Retailleau3, Bogdan I Iorga3, Thierry Naas1,2,4,6.   

Abstract

OXA-48 carbapenemase has rapidly spread in many countries worldwide with several OXA-48-variants being described, differing by a few amino acid (AA) substitutions or deletions, mostly in the β5-β6 loop. While single AA substitutions have only a minor impact on OXA-48 hydrolytic profiles, others with 4 AA deletions result in loss of carbapenem hydrolysis and gain of expanded-spectrum cephalosporin (ESC) hydrolysis. We have replaced the β5-β6 loop of OXA-48 with that of OXA-18, a clavulanic-acid inhibited oxacillinase capable of hydrolyzing ESCs but not carbapenems. The hybrid enzyme OXA-48Loop18 was able to hydrolyze ESCs and carbapenems (although with a lower kcat), even though the β5-β6 loop was longer and its sequence quite different from that of OXA-48. The kinetic parameters of OXA-48Loop18 were in agreement with the MIC values. X-ray crystallography and molecular modeling suggest that the conformation of the grafted loop allows the binding of bulkier substrates, unlike that of the native loop, expanding the hydrolytic profile. This seems to be due not only to differences in AA sequence, but also to the backbone conformation the loop can adopt. Finally, our results provide further experimental evidence for the role of the β5-β6 loop in substrate selectivity of OXA-48-like enzymes and additional details on the structure-function relationship of β-lactamases, demonstrating how localized changes in these proteins can alter or expand their function, highlighting their plasticity.

Entities:  

Keywords:  carbapenemase; expanded-spectrum cephalosporins; oxacillinases; β5−β6 loop

Mesh:

Substances:

Year:  2020        PMID: 32156115     DOI: 10.1021/acsinfecdis.9b00452

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  5 in total

1.  To Be or Not to Be an OXA-48 Carbapenemase.

Authors:  Laura Dabos; Saoussen Oueslati; Sandrine Bernabeu; Rémy A Bonnin; Laurent Dortet; Thierry Naas
Journal:  Microorganisms       Date:  2022-01-24

2.  Multiscale Simulations Identify Origins of Differential Carbapenem Hydrolysis by the OXA-48 β-Lactamase.

Authors:  Viivi H A Hirvonen; Tal Moshe Weizmann; Adrian J Mulholland; James Spencer; Marc W van der Kamp
Journal:  ACS Catal       Date:  2022-04-04       Impact factor: 13.700

3.  Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems.

Authors:  Vlatko Stojanoski; Liya Hu; Banumathi Sankaran; Feng Wang; Peng Tao; B V Venkataram Prasad; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2021-01-25       Impact factor: 5.084

4.  KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate.

Authors:  Agnès B Jousset; Saoussen Oueslati; Cécile Emeraud; Rémy A Bonnin; Laurent Dortet; Bogdan I Iorga; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

5.  Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations.

Authors:  Ørjan Samuelsen; Christopher Fröhlich; João A Gama; Klaus Harms; Viivi H A Hirvonen; Bjarte A Lund; Marc W van der Kamp; Pål J Johnsen; Hanna-Kirsti S Leiros
Journal:  mSphere       Date:  2021-04-28       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.